Browse by Audience
Skip to content
Papers of the Week
Blockade of BDNF Signaling Attenuates Chronic Visceral Hypersensitivity in an IBS-like Rat Model.
Abstract
Irritable bowel syndrome (IBS) is a common functional disease characterized by chronic abdominal pain and changes in bowel movements. Effective therapy for visceral hypersensitivity in IBS patients remains challenging. This study investigated the roles of brain-derived neurotrophic factor (BDNF) and tyrosine kinase receptor B (TrkB) and the effect of ANA-12 (a selective antagonist of TrkB) on chronic visceral hypersensitivity in an IBS-like rat model.